Ambit Capital has a ‘sell’ rating on the stock, with a price target of Rs 1,312. HDFC Securities sees it at Rs 1,400. Edelweiss Wealth has ‘buy’ on the counter with a target of Rs 2,365. Dalal & Broacha Stock Broking said downside is limited and long-term investors should hold, as it finds the stock Rs 2,001 worthy. Centrum sees it at Rs1,944 while Nirmal Bang Institutional Equities at Rs 2,240.
Tempsens Instrument IPO: GMP soars past 100%, signalling strong listing hopes
Tempsens Instruments IPO grey market premium has surged 100 percent. This marks the first IPO to cross this milestone in nearly two years. The IPO